CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (USD $)	Convertible Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Employee Advances	Treasury Stock	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2012	$ 395	$ 13,031	$ 16,460,385	$ (18,858)	$ (3,419,715)	$ (20,828,674)	$ (7,793,436)
Beginning Balance, Shares at Dec. 31, 2012	394,685	13,030,397			1,179,212
Stock-based compensation			558,286				558,286
Warrants issued to 2012 private placement investors			487,200				487,200
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount	27		261,057				261,084
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares	27,630
Cashless exercise of warrants into common stock, Amount		10,342	(10,342)
Cashless exercise of warrants into common stock, Shares		10,342,931
Contractual dividends on Series B convertible preferred stock						(279,380)	(279,380)
Beneficial conversion feature and deemed dividend on Series B convertible preferred stock			1,532,722			(1,532,722)
Warrants issued as debt discount in connection with notes payable			403,300				403,300
Conversion of notes and accounts payable into common stock and warrants, Amount		833	3,625,067				3,625,900
Conversion of notes and accounts payable into common stock and warrants, Shares		833,000
Issuance of common stock and warrants for cash, Amount		3,502	3,498,473				3,501,975
Issuance of common stock and warrants for cash, Shares		3,501,975
Imputed value of services contributed			350,000				350,000
Change in fair value of collateral securing employee advances				9,857			9,857
Net loss						(5,489,892)	(5,489,892)
Ending Balance, Amount at Dec. 31, 2013	422	27,708	27,166,147	(9,001)	(3,419,715)	(28,130,668)	(4,365,107)
Ending Balance, Shares at Dec. 31, 2013	422,315	27,708,303			1,179,212
Stock-based compensation			830,518				830,518
Shares issued as pursuant to employment agreement, Amount		21	10,625				10,646
Shares issued as pursuant to employment agreement, Shares		21,289
Warrants issued to 2012 private placement investors
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount	30		279,350				279,380
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares	29,564
Contractual dividends on Series B convertible preferred stock						(298,918)	(298,918)
Warrants issued as debt discount in connection with notes payable			36,000				36,000
Issuance of common stock and warrants for cash, Amount		11,022	1,526,733				1,537,755
Issuance of common stock and warrants for cash, Shares		11,020,003
Imputed value of services contributed			116,666				116,666
Change in fair value of collateral securing employee advances				6,858			6,858
Net loss						(1,783,279)	(1,783,279)
Ending Balance, Amount at Dec. 31, 2014	$ 452	$ 38,751	$ 29,966,039	$ (2,143)	$ (3,419,715)	$ (30,212,865)	$ (3,629,481)
Ending Balance, Shares at Dec. 31, 2014	451,879	38,749,595			1,179,212